Guidance on the use of the following obstetric drugs is to be found in each obstetric department in NHS Highland and is posted on the Maternity and Gynaecology Services webpage.

CARBOPROST

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 250 micrograms/mL (s)

DINOPROSTONE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Vaginal tablets 3mg (s)

Important: Formulation and dosage details

Formulation:

Vaginal delivery system 10mg (s)

ERGOMETRINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 500 micrograms/mL (s)

ATOSIBAN

Important: Therapy notes

  • May be considered for the inhibition of uncomplicated premature labour between 24 and 33 weeks of gestation
  • Refer to guidance and SPC.
  • See also NICE ESUOM11 (www.nice.org.uk).

Important: Formulation and dosage details

Formulation:

Injection 6·75mg/0·9mL (s)

Important: Formulation and dosage details

Formulation:

Concentrate for intravenous infusion 37·5mg/5mL (s)

CABERGOLINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 500 micrograms

Dosage:

For the prevention of lactation, during first day postpartum: 1mg as a single dose.
Suppression of established lactation: 250 micrograms every 12 hours for 2 days.

ENALAPRIL

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 2·5mg, 5mg, 10mg, 20mg (s)

Dosage:

First line for controlling hypertension in post-natal, breast-feeding women.

MIFEPRISTONE

Important: Therapy notes

  • Only supplied to NHS hospitals and premises approved under the Abortion Act 1967.

Important: Formulation and dosage details

Formulation:

Tablets 200mg (s)

MISOPROSTOL

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 100 micrograms unlicensed, 200 micrograms off-label (s)

OXYTOCIN

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 5 units/mL, 10 units/mL (s)

ERGOMETRINE WITH OXYTOCIN

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection (ergometrine 500 micrograms, oxytocin 5 units/mL) (Syntometrine®)

TERBUTALINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 500 micrograms/mL (s)

Document Id: F341